Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

Issue 8/2022

Content (6 Articles)

Anal Cancer Lower Gastrointestinal Cancers (AB Benson, Section Editor

The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies

Alexandre A. Jácome, Van Karlyle Morris, Cathy Eng

Acute Myeloid Leukemia Leukemia (PH Wiernik, Section Editor)

How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia

Jozal W. Moore, Nancy Torres, Michael Superdock, Jason H. Mendler, Kah Poh Loh

Open Access Lung Cancer Lung Cancer (TA Leal and N Sethakorn, Section Editors)

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Brian Schlick, Misty Dawn Shields, Julian A. Marin-Acevedo, Ishika Patel, Bruna Pellini

Lenvatinib Gynecologic Cancers (JS Ferriss, Section Editor)

Incorporating Molecular Diagnostics into Treatment Paradigms for Endometrial Cancer

Brenna E. Swift, Lilian T. Gien

Systemic Therapy Head and Neck Cancer (PL Swiecicki, Section Editor)

Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments

Luana Guimaraes de Sousa, Katarina Jovanovic, Renata Ferrarotto

Melanoma Correction

Correction to: Cardiotoxicity of Systemic Melanoma Treatments

Neha Mukunda, Srilakshmi Vallabhaneni, Benedicte Lefebvre, Michael G. Fradley

Jul 22
Issue: 7/2022
Sep 22
Issue: 9/2022

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits